Introduction
This report offers insight into PLM in the pharmaceutical industry, bringing together all briefs published for this theme. The report covers market trends, technological components which Datamonitor believes are key for this sector, and four critical vendor attributes used by pharmaceutical companies to select a PLM vendor.
Scope
- From Idea to Market: Product Lifecycle Management in the Pharmaceutical Industry (Market Focus)
- Optimizing PLM Technology for the Pharmaceutical Industry (Technology Focus)
- Managing Process Complexity in the Pharmaceutical Industry with PLM (Strategy Focus)
- Pharmaceutical PLM Forecast in North America, Europe and APAC 2006-2012 (Databooks)
Highlights
- Pharmaceutical product lifecycle management technology is gaining momentum
- PLM addresses key business challenges facing the pharmaceutical industry
- PLM is successful when treated as an enterprise, strategic initiative
Reasons to Purchase
- Gain valuable industry insight into the market drivers and inhibitors for product lifecycle management solutions in the life sciences market
- Align your go-to-market strategy with both the business and technology needs of the pharmaceutical industry
- Quantify the current and projected market opportunity for PLM in the pharmaceutical industry in North America, Western Europe, China and Japan.
Other selected research from the 'Markets' category:
Pricing and Reimbursement: Innovative Risk-Sharing Strategies
Novel niche biologics entering the market require high price points in order to provide manufacturers with a return on investment. However, with heightening regulatory scrutiny and increasing cost-pressures, a balance must be struck between incentivizing Pharma to develop novel drugs with high unmet needs, and that of the healthcare payers which fund healthcare costs. Learn More
The Asthma and COPD Market Outlook: Market analysis of future growth and leading players by sector
This unique product offering provides an analysis of changing market conditions and strategic future outlook using the gold standard IMS Health sales data and Business Insights ’ expert analysis, an unrivalled source of pharmaceutical intelligence on the asthma and COPD market. Learn More
